Truist Financial Corp Avanos Medical, Inc. Transaction History

Truist Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$22.53 - $30.98 $110,689 - $152,204	-4,913 Reduced 21.24%	18,216 $465,000
Q1 2023 May 05, 2023	BUY	$26.92 - $31.75 $134 - $158	5 Added 0.02%	23,129 $687,000
Q4 2022 Feb 17, 2023	BUY	$19.88 - $27.37 $459,705 - $632,903	23,124 New	23,124 $625,000
Q2 2022 Jul 22, 2022	BUY	$24.87 - $34.68 $413,836 - $577,075	16,640 New	16,640 $455,000
Q1 2021 May 17, 2021	SELL	$43.5 - $53.4 $123,148 - $151,175	-2,831 Closed	0 $0
Q4 2020 Nov 19, 2021	SELL	$33.15 - $49.5 $131,804 - $196,812	-3,976 Reduced 58.41%	2,831 $130,000
Q4 2020 Feb 18, 2021	BUY	$33.15 - $49.5 $225,652 - $336,946	6,807 New	6,807 $313,000

275

42.5M

5.4K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $865M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.